Clinical and radiological outcomes of spinal tuberculosis: a retrospective study - Takeaways - MDSpire
Coming Soon: Introducing MDSpire News. Learn more
Conexiant’s news site is now MDSpire News. Learn more

Clinical and Imaging Outcomes in Spinal Tuberculosis: A Retrospective Analysis

  • By

  • Akhilesh Sharma

  • Rebekah Merriman

  • Sinead Foley

  • Mollie Ward

  • Laura Gill

  • Ananna Rahman

  • Syed Aftab

  • Jonathan Bull

  • Veronica White

  • Akanksha Mimi Malhotra

  • Sivadas Ganeshalingham

  • Heinke Kunst

  • November 6, 2026

Share

  • 1

    This retrospective study evaluated 62 patients diagnosed with spinal tuberculosis at a London NHS Trust from 2011 through 2022.

  • 2

    Clinical and MRI assessments were reviewed at diagnosis, during treatment, and around 12 months. Median antituberculosis treatment duration was 12 months.

  • 3

    The cohort was 73% male, had a median age of 33 years, and included 84% migrants.

  • 4

    MRI severity was scored across five domains, and clinical symptoms were scored on an eight-point scale weighted by neurological severity.

  • 5

    Clinical and MRI scores improved more at 12 months than at 6 months. Long-term complications affected 19%; no relapses or TB-related deaths occurred.

Original Source(s)

Clinical and radiological outcomes of spinal tuberculosis: a retrospective study

  • by Akhilesh Sharma, Rebekah Merriman, Sinead Foley, Mollie Ward, Laura Gill, Ananna Rahman, Syed Aftab, Jonathan Bull, Veronica White, Akanksha Mimi Malhotra, Sivadas Ganeshalingham, Heinke Kunst

  • November 6, 2026

Related Content

FDA approves HPV immunotherapy for RRP

In a study of 32 adults with recurrent respiratory papillomatosis, treatment reduced the need for repeated surgery.

Medical Oddities: The ghost that haunted a heart

From haunted hearts to toxic treats, medicine has a few Halloween tricks up its sleeve.

May long COVID improve without full recovery?

Investigators found that symptom improvement remained possible years after infection, but patients with multisystem symptoms had lower likelihood of improvement.